X
    學術可視化工作室RC   登錄   提交文稿
學術英文編修

CURRENT CANCER DRUG TARGETS

期刊標題檢索 CURR CANCER DRU 最新評論: Charging article processing fees, not page fees (2023-07-21)


期刊名稱:   ISSN:   主題領域:   影響因子範圍: -
索引:   類別:   開放訪問:   排序方式:

[CURRENT CANCER DRUG TARGETS]您好,您是該頁面的第 36815 位訪客。

期刊簡介
期刊名稱CURRENT CANCER DRUG TARGETS CURRENT CANCER DRUG TARGETS
LetPub Score
6.6
50 ratings
Rate

Reputation
7.6

Influence
5.2

Speed
8.9

期刊簡稱CURR CANCER DRUG TAR
ISSN1568-0096
E-ISSN1873-5576
h-index85
CiteScore
CiteScoreSJRSNIPCiteScore Rank
5.400.6500.549
Subject fieldQuartilesRankPercentile
Category: Medicine
Subcategory: Oncology
Q2148 / 404
Category: Medicine
Subcategory: Pharmacology
Q2140 / 313
Category: Medicine
Subcategory: Drug Discovery
Q276 / 157
Category: Medicine
Subcategory: Cancer Research
Q3122 / 230

自引率 (2023-2024)0.00%自引率趨勢
掲載範囲
Current Cancer Drug Targets aims to cover all the latest and outstanding developments on the medicinal chemistry, pharmacology, molecular biology, genomics and biochemistry of contemporary molecular drug targets involved in cancer, e.g. disease specific proteins, receptors, enzymes and genes.

Current Cancer Drug Targets publishes original research articles, letters, reviews / mini-reviews, drug clinical trial studies and guest edited thematic issues written by leaders in the field covering a range of current topics on drug targets involved in cancer.

As the discovery, identification, characterization and validation of novel human drug targets for anti-cancer drug discovery continues to grow; this journal has become essential reading for all pharmaceutical scientists involved in drug discovery and development.
官方網站http://benthamscience.com/journal/index.php?journalID=ccdt
在線稿件提交http://bsp-cms.eurekaselect.com/index.php/CCDT
開放訪問No
出版商Bentham Science Publishers B.V.
主題領域医学
出版國/地區NETHERLANDS
發行頻率隔月刊行
創刊年2001
每年文章數70每年文章數趨勢
黃金OA百分比1.92%
Web of Science 四分位
2023-2024
WOS Quartile: Q3

CategoryEditionJIF QuartileJIF RankingJIF Percentage
ONCOLOGYSCIEQ3201/322
索引 (SCI or SCIE)Science Citation Index Expanded
鏈接到PubMed Central (PMC)https://www.ncbi.nlm.nih.gov/nlmcatalog?term=1568-0096%5BISSN%5D
平均審稿時間 *來自出版商的數據:
來自作者的數據: Average 1 Month(s)
競爭力 *來自作者的數據: About 50%
參考鏈接
相關期刊 【CURRENT CANCER DRUG TARGETS】CiteScore趨勢
自引率趨勢 每年文章數趨勢
作者評論
*所有的審稿過程指標,如接受率和審稿速度,僅限於用戶提交的稿件。因此,這些指標可能無法準確反映期刊的競爭力或速度。
  • 同一學科的期刊
  • CiteScore趨勢
  • 自引率趨勢
  • 每年文章數趨勢
  •  
    學科內的可信期刊 影響因子
    CA-A CANCER JOURNAL FOR CLINICIANSH-index: 144

    CiteScore: 873.20
    Nature Reviews Clinical OncologyH-index: 127

    CiteScore: 99.40
    NATURE REVIEWS CANCERH-index: 396

    CiteScore: 111.90
    ANNALS OF ONCOLOGYH-index: 210

    CiteScore: 63.90
    CANCER CELLH-index: 295

    CiteScore: 55.20
    JOURNAL OF CLINICAL ONCOLOGYH-index: 494

    CiteScore: 41.20
    LANCET ONCOLOGYH-index: 274

    CiteScore: 62.10
    CANCER RESEARCHH-index: 411

    CiteScore: 16.10
    SEMINARS IN CANCER BIOLOGYH-index: 134

    CiteScore: 26.80
    JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCHH-index: 67

    CiteScore: 18.20
    學科內最受檢索的期刊 頁面查看次數
    CANCER LETTERS326409
    CANCER RESEARCH311013
    BMC CANCER242878
    JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH197893
    INTERNATIONAL JOURNAL OF CANCER188347
    Asian Pacific Journal of Cancer Prevention188285
    CLINICAL CANCER RESEARCH180970
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY171732
    ONCOLOGY REPORTS171323
    CA-A CANCER JOURNAL FOR CLINICIANS163285
  •  

    CURRENT CANCER DRUG TARGETS CURRENT CANCER DRUG TARGETS
    明年預測:
    穩步上升 無變化 逐步下降  刷新
  •  

     
  •  

     


首頁    上一頁    1    2    下一頁    末頁  (頁
/2)
  [CURRENT CANCER DRUG TARGETS] 的評論撰寫評論
作者: 金刚统维


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-07-21 17:18:18 評論於
Charging article processing fees, not page fees
(0) 讚! | 金刚统维

作者: 东木以东


領域: 生物学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-04-24 09:20:07 評論於
On April 24, 2023, in the copy editing state, it is unclear what it specifically means.
(0) 讚! | 东木以东

作者: 紫易小可爱


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-03-13 16:17:23 評論於
Hello, excuse me, does this magazine cost money?
(0) 讚! | 紫易小可爱

作者: Ula Salome


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-02-21 17:29:08 評論於
Where can I check the progress? I can't find the page to enter the number. Thank you
(0) 讚! | Ula Salome

作者: 金刚统维


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-02-04 19:51:25 評論於
Submission acceptance rate: 50.0
Experience sharing: The quality of the journal is good, and the review speed has recently increased. Generally, external reviews take about 2 months, and acceptance can be expected in around 4 months
(0) 讚! | 金刚统维

作者: 金刚统维


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-02-01 23:21:39 評論於
Review speed: 3.0 | Submission hit rate: 50.0
Research focus: Tumor
Experience sharing: The quality of the journal is good, and the review speed has recently increased. Moreover, you can check the progress of the article by entering the input number of the submission system. [PS: By changing the number, you can also refer to the progress of other articles] It is recommended for everyone to submit articles, as there is a relatively large potential for improvement in scores
(0) 讚! | 金刚统维

作者: 终幕音悦


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-01-31 17:23:18 評論於
How can I upload the picture that needs to be modified?
(0) 讚! | 终幕音悦

作者: 桃花静慧


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-01-17 09:02:15 評論於
No response after two months of submission, I am ready to withdraw the manuscript
(0) 讚! | 桃花静慧

作者: tangletpub


領域: 医学
審稿時間: 2.0 month(s)
結果: 修改後接受


撰寫評論

2022-09-15 21:19:13 評論於
Senior, how long after acceptance will the proofreading be done? How long until it goes online? How long until it is published?
(0) 讚! | tangletpub

作者: 回风癸卯


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2022-06-13 12:49:51 評論於
Research focus: Tumor experience sharing: Review process is extremely slow, it's been 3 months since submission, no progress at all
(0) 讚! | 回风癸卯

作者: 娴娴


領域: 医学
審稿時間: 2.0 month(s)
結果: 修改後接受


撰寫評論

2022-03-21 16:57:22 評論於
2021-9-24 Post
10.06 In Review
11.17 With Author, For Revision
11.19 Revised
11.22 Awaiting Editorial Approval
12.13 Final Verification of Content
2.10 In Copy Editing
2.21 In Composing
(1) 讚! | 娴娴

作者: 维尔娜菲茨杰拉德


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-12-30 19:33:16 評論於
Nearly all freely submitted academic papers that meet the publication requirements after review need to be returned to the authors for revisions before being published. This may include rewording, formatting changes such as compressing the length of the article, redesigning tables, improving the quality of illustrations, and limiting the use of irregular abbreviations. However, returning a revised manuscript to the authors does not mean that the article has been accepted. Whether the article is ultimately accepted depends on whether the author's modifications to the key content and presentation of the article meet the requirements of the reviewers and editors.

The materials typically returned to the authors for revisions include the original manuscript, reviewers' comments, and a covering letter from the editor. When authors receive the revised manuscript, they should carefully read the covering letter and reviewers' comments. They should then consider whether they can or are willing to accept the suggestions from the reviewers or editor and make revisions. The likelihood of the article being accepted can be seen from the response letter from the editor and the revised comments from the reviewers. Revisions should not be rushed; authors should carefully read and understand the reviewers' issues. They should respond to each reviewer's comments individually, specify where changes have been made in the revised manuscript (page, lines), and write a response letter to the editor acknowledging the suggestions for modifications and explaining any reasons for not making certain changes
(0) 讚! | 维尔娜菲茨杰拉德

作者: 维尔娜菲茨杰拉德


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-12-30 08:55:15 評論於
Revised, that is, modifying the reply. In the submission and publication of articles in SCI journals, making appropriate modifications to the editor's letter and explaining the modified content in detail in the reply to the editor, is one step to apply for re-review of the manuscript
(0) 讚! | 维尔娜菲茨杰拉德

作者: Darlene Pepys


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-12-26 21:51:59 評論於
What does the proposal include?
(0) 讚! | Darlene Pepys

作者: 北国博达


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-12-26 15:38:49 評論於
What is the process of returns?
(0) 讚! | 北国博达

作者: 苍风静涵


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2019-11-13 22:49:07 評論於
It seems like there was no reviewer? It's been two months and there were no comments at all, just a straight rejection. This is unbelievable, it's really delaying things
(0) 讚! | 苍风静涵

作者: 仲夏和颂


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2018-02-21 12:15:48 評論於
Is there a layout fee?
sky007 2018-01-16 Posted:: Review time: about 3 months Received: March 05, 2017 Revised: October 10, 2017 Accepted: October 17, 2017 Graphical Abstract needs to be submitted in the final version. Do you need help understanding this?
(0) 讚! | 仲夏和颂

作者: 小野寺娅欣


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2018-01-16 20:54:23 評論於
Review Speed: 3.0  Experience Sharing: Received: March 05, 2017  Revised: October 10, 2017  Accepted: October 17, 2017  Do you need to submit Graphical Abstract in the proofreading process?
(0) 讚! | 小野寺娅欣

作者: 凌霄高洁


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2017-07-18 16:33:27 評論於
The past was good, but it's really scary to see things fall so much now. I hope to get back to a three point level next year, but it might be too difficult
(0) 讚! | 凌霄高洁

作者: 仲夏贞韵


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2017-06-30 17:52:32 評論於
Submitted in April, no news at all, it's like a stone sinking in the ocean. Wrote a letter to inquire, but no reply. Graduating soon, feeling at a loss
(0) 讚! | 仲夏贞韵

作者: 火焰鸿吉


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2017-05-17 23:36:29 評論於
I submitted for 2 months, but all I got was a straight rejection without any feedback. Hehe
(0) 讚! | 火焰鸿吉

作者: 凌霄高洁


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2013-03-29 21:41:09 評論於
This journal recently changed the editorial team, including EIC. Hopefully things will move much faster. But its rejection rate may increase
(0) 讚! | 凌霄高洁

作者: 凌霄高洁


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2012-10-29 23:52:23 評論於
This magazine publishes very few articles each year, only 80-100. The review process is very slow
(0) 讚! | 凌霄高洁

作者: 凌霄高洁


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2012-08-24 08:55:05 評論於
The submission process is very slow, usually taking 2-3 months to be reviewed, 8-10 months to decide whether to publish, and there is also the risk of rejection. If time is tight, it is better not to submit
(0) 讚! | 凌霄高洁

作者: 凌霄高洁


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2011-09-25 09:25:05 評論於
There is a link in the magazine introduction, why don't you just open it? http://www.benthamscience.com/ccdt/
(0) 讚! | 凌霄高洁

首頁    上一頁    1    2    下一頁    末頁  (頁
/2)

開始撰寫 [CURRENT CANCER DRUG TARGETS] 的評論:





Contact us

Contact us  

Your name*

Your email*

Your message*

Please fill in all fields and provide a valid email.

Security Code*